# Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF

> **NCT06884904** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **National Engineering Center of Cell Products** · enrollment: 96 (estimated)

## Conditions studied

- Acute-On-Chronic Liver Failure

## Interventions

- **DRUG:** Low-dose experimental group
- **DRUG:** High-dose experimental group
- **DRUG:** Low-dose placebo control group
- **DRUG:** High-dose placebo control group

## Key facts

- **NCT ID:** NCT06884904
- **Lead sponsor:** National Engineering Center of Cell Products
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2027-04-14
- **Final completion:** 2028-04-14
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06884904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06884904, "Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06884904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*